APEIRON Capital Ltd Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
|
+$4.33M |
| 2 |
NVO
Novo Nordisk
NVO
|
+$3.3M |
| 3 |
Wolfspeed
WOLF
|
+$1.73M |
| 4 |
On Holding
ONON
|
+$1.37M |
| 5 |
ProShares UltraPro Short QQQ
SQQQ
|
+$702K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pinduoduo
PDD
|
+$11.9M |
| 2 |
TSMC
TSM
|
+$8M |
| 3 |
Super Micro Computer
SMCI
|
+$6.23M |
| 4 |
Microsoft
MSFT
|
+$6.1M |
| 5 |
NVIDIA
NVDA
|
+$4.91M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 27.35% |
| 2 | Healthcare | 15.28% |
| 3 | Communication Services | 5.23% |
| 4 | Technology | 3.34% |
| 5 | Financials | 0% |
Similar funds
APEIRON Capital Ltd's Q3 2023 Portfolio in Review
As of Q3 2023, APEIRON Capital Ltd held 17 positions worth $149M, down 9.7% from $165M the previous quarter. Its ten largest holdings account for 99% of the portfolio.
APEIRON Capital Ltd withdrew a net $81.9M in Q3 2023, closing 6 positions and reducing 4 holdings. Its most notable exit was TSMC, an estimated $8M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 27% of assets, down from 31% a quarter earlier, followed by Healthcare and Communication Services.
Against the trend, APEIRON Capital Ltd opened a new position in Shockwave Medical, Inc. Common Stock worth $3.64M.
- APEIRON Capital Ltd's largest Q3 2023 buy was Shockwave Medical, Inc. Common Stock: 18,300 shares worth $3.64M.
- APEIRON Capital Ltd added most to Wolfspeed in Q3 2023, an estimated $1.73M increase.
- APEIRON Capital Ltd's biggest Q3 2023 reduction was Pinduoduo, cutting an estimated $11.9M.
- APEIRON Capital Ltd fully exited TSMC in Q3 2023, selling an estimated $8M.
- APEIRON Capital Ltd's ten largest holdings make up 99% of its $149M portfolio in Q3 2023.
- APEIRON Capital Ltd opened 3 new positions and closed 6 in Q3 2023.
- APEIRON Capital Ltd's portfolio value fell 9.7% quarter-over-quarter to $149M.
Based on APEIRON Capital Ltd's 13F filing for Q3 2023, filed 31 Oct 2023.